Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease

Pompe disease is caused by mutations in lysosomal acid α-glucosidase (GAA) and patients are being treated with recombinant human α-glucosidase (rhGAA). Here the authors present the crystal structures of rhGAA and its complexes with inhibitors and a pharmacological chaperone, which is important for d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Véronique Roig-Zamboni, Beatrice Cobucci-Ponzano, Roberta Iacono, Maria Carmina Ferrara, Stanley Germany, Yves Bourne, Giancarlo Parenti, Marco Moracci, Gerlind Sulzenbacher
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/1092edf30ccd4d65964b3a4b8b5fdd66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1092edf30ccd4d65964b3a4b8b5fdd66
record_format dspace
spelling oai:doaj.org-article:1092edf30ccd4d65964b3a4b8b5fdd662021-12-02T14:42:16ZStructure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease10.1038/s41467-017-01263-32041-1723https://doaj.org/article/1092edf30ccd4d65964b3a4b8b5fdd662017-10-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-01263-3https://doaj.org/toc/2041-1723Pompe disease is caused by mutations in lysosomal acid α-glucosidase (GAA) and patients are being treated with recombinant human α-glucosidase (rhGAA). Here the authors present the crystal structures of rhGAA and its complexes with inhibitors and a pharmacological chaperone, which is important for drug development.Véronique Roig-ZamboniBeatrice Cobucci-PonzanoRoberta IaconoMaria Carmina FerraraStanley GermanyYves BourneGiancarlo ParentiMarco MoracciGerlind SulzenbacherNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Véronique Roig-Zamboni
Beatrice Cobucci-Ponzano
Roberta Iacono
Maria Carmina Ferrara
Stanley Germany
Yves Bourne
Giancarlo Parenti
Marco Moracci
Gerlind Sulzenbacher
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
description Pompe disease is caused by mutations in lysosomal acid α-glucosidase (GAA) and patients are being treated with recombinant human α-glucosidase (rhGAA). Here the authors present the crystal structures of rhGAA and its complexes with inhibitors and a pharmacological chaperone, which is important for drug development.
format article
author Véronique Roig-Zamboni
Beatrice Cobucci-Ponzano
Roberta Iacono
Maria Carmina Ferrara
Stanley Germany
Yves Bourne
Giancarlo Parenti
Marco Moracci
Gerlind Sulzenbacher
author_facet Véronique Roig-Zamboni
Beatrice Cobucci-Ponzano
Roberta Iacono
Maria Carmina Ferrara
Stanley Germany
Yves Bourne
Giancarlo Parenti
Marco Moracci
Gerlind Sulzenbacher
author_sort Véronique Roig-Zamboni
title Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
title_short Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
title_full Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
title_fullStr Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
title_full_unstemmed Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
title_sort structure of human lysosomal acid α-glucosidase–a guide for the treatment of pompe disease
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/1092edf30ccd4d65964b3a4b8b5fdd66
work_keys_str_mv AT veroniqueroigzamboni structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT beatricecobucciponzano structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT robertaiacono structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT mariacarminaferrara structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT stanleygermany structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT yvesbourne structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT giancarloparenti structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT marcomoracci structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
AT gerlindsulzenbacher structureofhumanlysosomalacidaglucosidaseaguideforthetreatmentofpompedisease
_version_ 1718389735310753792